The CCRE platform is a multi-province (Ontario, Alberta and British Columbia) collaboration. The mission of the CCRE Platform is to generate Canadian real-world evidence (RWE) that can respond to queries from senior healthcare decision-makers about the safety and effectiveness of post-market oncology therapies.
The CCRE platform will: i) provide timely access to large administrative datasets to generate population-based estimates of measures of safety and effectiveness of oncology therapies; ii) leverage pan-Canadian data to develop comprehensive comparative analyses of oncology therapies to evaluate generalizability and regional variation in the provision of care and outcomes; iii) develop and standardize methodological approaches for generating oncology RWE; and iv) build capacity and develop training for highly qualified personnel in the areas of safety and effectiveness analytics.
Co-Principal Investigators: Stuart Peacock, BC Cancer, Simon Fraser University; Kelvin Chan, Sunnybrook Odette Cancer Centre, University of Toronto; Winson Cheung, University of Calgary; Scott Gavura, Ontario Health; J Irish; M Tadrous
Principal Investigators: Dr. Renelle Myers, Vancouver General Hospital, University of British Columbia, BC Cancer; Dr. Rayjean Hung, Mount Sinai Hospital, University of Toronto
Principal Investigator: Steven Gallinger, Princess Margaret Cancer Centre, University of Toronto
Co-Principal Investigators: Stuart Peacock, BC Cancer, Simon Fraser University; Francois Bernard, BC Cancer, University of British Columbia; J Valliant; F Prato, W Isaranu-watchai, F Wuest, J Beauregard, K Zukotynski, K Chi, F Saad
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.